Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06271993 · ClinicalTrials.gov registry record · NA

SPT for Sensitization of Collagen Dressing

A NA study, sponsored by Covalon Technologies.

Completed
Registry status
NA
Development phase
27
Enrollment target

NCT06271993 is a NA study that has completed, run by Covalon Technologies. The registered enrollment target is 27 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06271993, a NA study, has completed, sponsored by Covalon Technologies.

COMPLETED
Registry status
NA
Development phase
27 participants
Enrollment target

Study Summary

The goal of this clinical trial is to determine the sensitization (contact allergy) potential of the test product ColActive Plus Collagen Matrix Dressing after a skin prick test on the skin of healthy human subjects. The main question it aims to answer is: • Does the product induce any sensitization (contact allergy) after a skin prick using a UniTest PC (pain control) device in healthy human subjects? Participants will have the test product and both positive and negative controls applied, and skin response will be evaluated by an allergist at 15 minutes, 6 hours, and 24-48 hours post-application to see if sensitization occurs.

Interventions

  • DEVICE ColActivePlus Collagen Matrix Dressing

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2024-02-08
Est. Completion 2024-02-16
Phase NA

Sponsor

Covalon Technologies

4 total trials

What the Registry Record Tells You About NCT06271993

The ClinicalTrials.gov registry entry for NCT06271993 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Covalon Technologies, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which ColActivePlus Collagen Matrix Dressing is the first listed.

NCT06271993 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06271993 about?

NCT06271993 is a clinical study titled "SPT for Sensitization of Collagen Dressing". The goal of this clinical trial is to determine the sensitization (contact allergy) potential of the test product ColActive Plus Collagen Matrix Dressing after a skin prick test on the skin of healthy human subjects. The main question it aims to answer is: • Does the product induce any sensitizatio...

What is the current status of trial NCT06271993?

This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2024-02-08. Estimated completion is 2024-02-16.

What interventions are being tested in trial NCT06271993?

The interventions under investigation include: ColActivePlus Collagen Matrix Dressing (DEVICE).

Who is sponsoring clinical trial NCT06271993?

This trial is sponsored by Covalon Technologies, which has 4 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.